Discover how the final rule from the CDC expands access to the World Trade Center (WTC) Health Program, now including Pentagon and Shanksville responders. This course unpacks the statutory changes, capped at 500 new enrollees, detailing the impact and compliance with...
Compliance with 21 CFR 211.110: A Comprehensive Guide
$9.99
This course offers in-depth insights into the FDA’s draft guidance on 21 CFR 211.110. Learn how to ensure batch uniformity and drug product integrity using advanced manufacturing techniques. Explore the integration of process models into control strategies to meet regulatory standards.
In this course you will learn the following:
* Understand the key requirements of 21 CFR 211.110 for drug product manufacturing.
* Identify the role of advanced manufacturing techniques in ensuring product quality.
* Recognize the importance of process models in manufacturing control strategies.
* Comprehend the FDA’s support for pharmaceutical innovation and modernization.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Additional information
| Federal Register Title | Considerations for Complying With 21 CFR 211.110; Draft Guidance for Industry; Availability. Document Number: 2024-31356 |
|---|---|
| Course SKU | FR-25-379-1 |
| Why This Course Is Important | A thorough understanding of how to implement FDA's guidance on batch uniformity and drug product integrity, which is crucial for maintaining compliance and ensuring high-quality production in the pharmaceutical industry. |